Renal function and bisphosphonate safety.
Ott
Susan M
SM
Drueke
Tilman
T
Elder
Grahame
G
Fukagawa
Masafumi
M
Jorgetti
Vanda
V
Langman
Craig B
CB
Moe
Sharon
S
McCann
Linda
L
Wang
Angela Yee-Moon
AY
Weisinger
Jose
J
Wheeler
David
D
D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000009:adverse effects / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000378:metabolism; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D051437:Renal Insufficiency / Q000150:complications* / Q000503:physiopathology
D050071:Bone Density Conservation Agents; D003404:Creatinine; D019386:Alendronate